Archive for October, 2006



FDA Warns About Decorative Contacts

Wearing decorative contact lenses without talking to an eye-care professional carries serious risks, the U.S. Food and Drug Administration warned on a day when many people may be considering going for an evil …
Comment

MSN MoneyCentral - In August, the Food and Drug Administration rejected an application for the company’s attention deficit hyperactivity disorder drug candidate Sparlon, which was a formulation of Provigil. The FDA rejected the application on safety grounds. Cephalon …

Sara Lee recalls hamburger buns

Sara Lee Food & Beverage Co. is recalling its 12-ounce Premium White Hamburger Buns in North and South Carolina.
Comment

Health officials say a salmonella outbreak potentially linked to produce has sickened at least 172 people in 18 states, including Tennessee.
Comment

The Food and Drug Administration accepted Bionovo Inc.’s protocol for an early-stage clinical trial of BZL101, a drug for metastatic breast cancer.

San Francisco Business Journal - The Food and Drug Administration accepted Bionovo Inc. ’s protocol for an early-stage clinical trial of BZL101, a drug for metastatic breast cancer. Emeryville-based Bionovo (OTCBB: BNVI) said Tuesday that the Phase I/II trial will be run at 10 …

Cytel Inc, the leading provider of clinical trial consulting services and software, announced today that Cytel’s Dr.
Comment

AVANIR Pharmaceuticals announced that it has received an approvable letter from the U.S. Food and Drug Administration for Zenvia for the treatment of involuntary emotional expression disorder .
Comment

MSN MoneyCentral - In May 2005, the company received orphan drug status from the Food and Drug Administration. The FDA status provides similar incentives, and seven years of U.S. marketing exclusivity upon approval. © 2006 The Associated Press. All rights reserved …

National Institute of Allergy and Infectious Diseases (NIAID), Staph Vaccine Shows Promise in Mouse Study, October 30, 2006

Sanofi-Aventis posted a better-than-expected third-quarter profit Tuesday due to generic rivalry to heart drug Plavix and government health cuts.
Comment

Bioniche Life Sciences Inc. , a research-based, technology-driven Canadian biopharmaceutical company, today announced that Graeme McRae, President & CEO, is scheduled to present at the Rodman & Renshaw 8th …
Comment

This limited recall is being conducted as a precaution because the 4,826 packages included may contain undeclared milk, posing a potential risk to milk-allergic individuals because the ingredient statement does not include milk.

MSN MoneyCentral - The companies were partnering to develop a high blood pressure treatment, but the Food and Drug Administration rejected the application, ending their agreement. In addition, royalties from Mylan Pharmaceuticals slipped, the company said. © 2006 The …

MSN MoneyCentral - Food and Drug Administration for the treatment of ALS in May 2005. Orphan drug status in the U.S. holds numerous potential benefits, including opportunities for grant funding toward clinical trial costs, tax advantages, FDA user-fee benefits …




About

You are currently browsing the Regulatory Affairs Syndicator weblog archives for October, 2006.

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories